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ABSTRACT
MSH6, a key component of the MSH2–MSH6
complex, plays a fundamental role in the repair of
mismatched DNA bases. Herein, we report that
MSH6 is a novel Ku70-interacting protein identified
by yeast two-hybrid screening. Ku70 and Ku86
are two key regulatory subunits of the DNA-
dependent protein kinase, which plays an essen-
tial role in repair of DNA double-strand breaks
(DSBs) through the non-homologous end-joining
(NEHJ) pathway. We found that association of
Ku70 with MSH6 is enhanced in response to treat-
ment with the radiomimetic drug neocarzinostatin
(NCS) or ionizing radiation (IR), a potent inducer
of DSBs. Furthermore, MSH6 exhibited diffuse
nuclear staining in the majority of untreated cells
and forms discrete nuclear foci after NCS or IR treat-
ment. MSH6 colocalizes with c-H2AX at sites of DNA
damage after NCS or IR treatment. Cells depleted of
MSH6 accumulate high levels of persistent DSBs, as
detected by formation of c-H2AX foci and by the
comet assay. Moreover, MSH6-deficient cells were
also shown to exhibit impaired NHEJ, which could
be rescued by MSH6 overexpression. MSH6-
deficient cells were hypersensitive to NCS- or
IR-induced cell death, as revealed by a clonogenic
cell-survival assay. These results suggest a potential
role for MSH6 in DSB repair through upregulation of
NHEJ by association with Ku70.
INTRODUCTION
DNA double-strand breaks (DSBs) are considered to be
the most biologically damaging lesions produced by
ionizing radiation (IR) and certain chemicals (1). DSBs
are more prone to unsuccessful or inaccurate DNA
repair due to the lack of a complementary template.
Unrepaired DNA damage can lead to cell-cycle arrest
and apoptosis, while accumulation of inaccurate repairs
can lead to chromosomal instability and carcinogenesis
(2). Homologous recombination (HR) and non-
homologous end-joining (NHEJ) are the two principal
pathways that mediate repair of DSBs in eukaryotic cells
(1,3). HR utilizes the homologous sister chromatid or
homologous chromosome as a template, resulting in
error-free repair of the missing information in the
damaged DNA. In contrast, NHEJ is referred to as an
intrinsically error-prone-repair pathway because this
process joins the two broken-DNA ends without using a
homologous template. In NHEJ, bases are generally
deleted or inserted as a part of repair of the DSB.
Despite the mutagenic nature of NHEJ, this pathway is
responsible for repairing a major fraction of DNA DSBs
in higher eukaryotes.
NHEJ is a complex process, requiring many protein
components. To initiate NHEJ, Ku70 binds the broken
DNA ends as a ring-shaped heterodimer complex
together with Ku86 (4). The Ku complex binds free
ends without any sequence speciﬁcity, leading to recruit-
ment of the catalytic subunit of the DNA-dependent
protein kinase (DNA-PKCS), a member of the phosphati-
dylinositol 3-kinase family. Together, Ku70, Ku86 and
DNA-PKCS form the active DNA–PK complex.
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double-stranded DNA activates the kinase activity of
DNA-PKCS. Subsequently, ligase IV and its cofactor,
XRCC4, are recruited to perform ligation of the
free DNA ends (4–6). Thus, DNA-PKCS and Ku70 are
essential for the initiation of NHEJ repair and are
rate-limiting.
The Ku proteins were originally identiﬁed as
autoantigens in patients with scleroderma polymyositis
syndrome (7). Ku70 is made up of 609 amino acids,
generating a 70-kDa protein, and forms a heterodimer
with the 80-kDa Ku86 subunit (also known as Ku80),
which consists of 732 amino acids. Both Ku proteins
have an intrinsic nuclear localization signal and primarily
localize to the nucleus (8). Ku70 and Ku86 show only 14%
homology to one another. However, structural analysis of
the two proteins bound to double-stranded DNA has
shown that the two proteins are structurally similar,
despite the lack of sequence homology.
Ku proteins are multifunctional proteins that possess
deubiquitylation activity and play a key role in DNA
repair and transcriptional regulation (9–12). Substantial
biochemical evidence also indicates that various proteins
physically interact with the Ku complex. For example,
Ku70/80 interacts with both the protein and RNA com-
ponents of human telomerase, suggesting that the Ku
complex is involved in telomere maintenance in higher
eukaryotes (13,14). The Ku complex has been shown to
inhibit apoptosis through an association with the
proapoptotic factor Bax (15). Interactions between Ku70
and p18-cyclin E, and Ku70 and Bax, provide a balance
between apoptosis and cell survival in response to
genotoxic stress (16). Ku70 interacts with Runx3 in the
nucleus, suggesting a possible link between a tumor sup-
pressor function and DNA repair (17). The human
Werner-syndrome protein (WRN), which is a member of
the RecQ helicase family, also interacts with Ku70/80, and
these proteins are thought to serve a function in one or
more pathways of DNA metabolism (18,19). The Ku70/80
complex also binds RAG1, providing a biochemical link
between the two phases of V(D)J recombination.
Furthermore, the cell polarity protein Par3 plays a role
in efﬁcient repair of DSBs through association with the
DNA–PK complex (20).
In this study, we report that Ku70 associates physically
with the mismatch repair (MMR) protein MSH6. MMR
is a highly conserved DNA-repair pathway, and defective
MMR is strongly associated with hereditary non-
polyposis colorectal cancer (HNPCC) (21). In addition
to a role in correcting mismatches formed during replica-
tion, MMR has recently been implicated in DSB repair
after exposure to g-irradiation (22–25). Our results
indicate that MSH6-deﬁcient cells have a major DSB-
repair defect, shown by both the presence of g-H2AX
foci and by comet-tail analysis. Further biochemical
analyses show that MSH6 knockdown or overexpression
leads to downregulation or upregulation of NHEJ,
respectively. These results suggest that MSH6 is involved
in the repair of DSBs through a direct physical interaction
with Ku70.
MATERIALS AND METHODS
Cell culture and drug treatment
The human cervix adenocarcinoma cell line HeLa and
the human embryonic kidney cell line HEK293T
were cultured in Dulbecco’s modiﬁed Eagle’s medium
(Gibco-BRL, Grand Island, NY, USA). The DLD1
colon cancer cell line was cultured in RPMI-1640
medium (Gibco-BRL). In both cases, the media was sup-
plemented with 10% heat-inactivated fetal bovine serum
(Cambrex Corp., East Rutherford, NJ, USA),
100units/ml penicillin, and 100mg/ml streptomycin
sulfate (Invitrogen, Carlsbad, CA, USA). All cells were
maintained in a humidiﬁed incubator containing 5%
CO2 at 37 C. HeLa and DLD1 cell lines were obtained
from the American Type Culture Collection (ATCC,
Rockville, MD, USA), and the HEK293T cell line was
obtained from the Cornell Institute for Medical
Research (New York, NY, USA). To induce DNA
breaks, exponentially growing cells were treated with the
radiomimetic drug neocarzinostatin (NCS; Sigma,
St Louis, MO, USA) at a ﬁnal concentration of
100ng/ml in fresh cell media or irradiated at 5 Gray
(Gy) from
137Cs source (Gammacell 3000 Elan irradiator,
Best Theratronics, Ottawa, Canada) and allowed to
recover at 37 C for various amounts of time.
Generation of stable MSH6 knockdown clones
The pSilencer2.1–U6 neo vector were obtained from
Ambion (Austin, TX, USA). Vectors for expression of
hairpin siRNAs were constructed by inserting correspond-
ing pairs of annealed DNA oligonucleotides into the
pSilencer 2.1–U6 vector between the BamHI and HindIII
restriction sites according to the manufacturer’s instruc-
tions. The MSH6-speciﬁc target sequence was selected
based on an online shRNA application from Invitrogen
(http://www.ambion.com/techlib/nisc/psilencer-converter
.html) using the human MSH6 sequence as the reference
sequence (GenBank Accession No. NM_000179.2). The
target sequences were 50-GCCAGACACUAAGGAGGA
AdTdT-30 (sense)and50-UUCCUCCUUAGUGUCUGG
C dTdT-30 (antisense) for MSH6 siRNA #1 and 50-GCGA
CUGUUCUAUAACUUUdTdT-30 (sense)and50-AAAG
UUAUAGAACAGUCGCdTdT-30 (antisense) for MSH6
siRNA #2. A non-targeting sequence, 50-CCUACGCCAC
CAAUUUCGU dTdT-30 and 50-ACGAAAUUGGUGG
CGUAGG dTdT-30, was used as a negative control. To
generate single knockdown clones, HeLa cells were trans-
fected with pSilencer2.1–U6, pSilencer2.1–U6 MSH6
siRNA #1 or pSilencer2.1–U6 MSH6 siRNA #2.
Twenty-four hours after transfection, 400mg/ml G418
was added to the culture medium for selection. After selec-
tion, stable clones were analyzed by real-time RT-PCR and
western blotting to conﬁrm downregulation of MSH6.
Plasmid constructs
The full-length Ku70 cDNA was ampliﬁed from
GM00637 human ﬁbroblast cells by RT-PCR using the
Ku70 primers 50-AATCTCGAGATGTCAGGGTGGG
AG-30 (sense) and 50-AATGGGCCCTCAGTCCTGGA
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struct was cloned into the mammalian expression vector
pcDNA3 in-frame with the hemagglutinin (HA) tag. The
Ku70 sequence was conﬁrmed by automated DNA
sequencing. The human MSH6 expression vector and its
control vector were obtained from Origene (OriGene
Technologies, Inc., Rockville, MD, USA).
Antibodies
The following antibodies were used for immunoblotting:
mouse monoclonal anti-MSH6 (1:2000 BD Transduction
Laboratories, Franklin Lakes, NJ, USA), mouse
monoclonal anti-MSH2 (1:2000; Calbiochem, San Diego,
CA, USA), monoclonal anti-Ku70 (1:2000; BD
Transduction Laboratories), monoclonal anti-XRCC4
(BD Transduction Laboratories), monoclonal anti-DNA-
PKCS (1:2000; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), polyclonal anti-Ku86 (1:2000; Santa Cruz
Biotechnology), monoclonal anti-HA tag (1:2000; Santa
Cruz Biotechnology) and monoclonal anti-a-tubulin
(1:8000; Neomarkers, Fremont, CA, USA). MSH6 foci
were detected by immunoﬂuorescence staining using the
MSH6 antibody (H-141; Santa Cruz Biotechnology) at a
1:50 dilution. g-H2AX foci were detected by immunoﬂuor-
escence staining using the g-H2AX mouse monoclonal
antibody (JBW301, Upstate Biotechnology, Temecula,
CA, USA) at a 1:200 dilution. Immunoprecipitations of
endogenous and exogenous proteins were performed
using rabbit polyclonal antibodies directed against MSH6
(ab50604; Abcam, Cambridge, UK) and Ku70 (H-308;
Santa Cruz Biotechnology).
Yeast two-hybrid analysis
The full-length Ku70 was sub-cloned into pGBT9 vector,
which expresses proteins fused to the GAL4-DNA-
binding domain (DNA-BD) (Clontech, Mountain View,
CA, USA). This vector was used as bait to screen a
human prostate cDNA library fused to the GAL4 activa-
tion domain according to the manufacturer’s (Clontech)
instructions. Positive clones were veriﬁed by ono-on-one
transformation and selection on agar plates lacking
leucine and tryptophan (-LH) or adenine, histidine,
leucine and tryptophan (-AHLT) and also processes for
a b-galactosidase assay.
Immunoprecipitation assay and western-blot analysis
Cells were lysed in ice-cold NP-40 lysis buffer [50mM
Tris–HCl (pH 8.0), 150mMNaCl, 1% Nonidet P-40] con-
taining ethylenediaminetetraacetic acid (EDTA)-free
protease inhibitor cocktail (Roche, Basel, Switzerland).
Equal amounts of proteins were then resolved on 6–15%
SDS-PAGE gels, followed by electrotransfer to poly-
vinylidene diﬂuoride membranes (Millipore, Bedford,
MA, USA). The membranes were blocked for 2h in
TBS-t [10mM Tris–HCl (pH 7.4), 150mMNaCl, 0.1%
Tween 20] containing 5% fat-free milk at room tempera-
ture and then incubated with the indicated primary
antibodies overnight at 4 C. After incubation for 2h
with appropriate peroxidase conjugated secondary
antibodies, developed using enhanced chemiluminescence
detection system.
For the immunoprecipitation assay, aliquots of soluble
cell lysates were precleared with protein A/G plus- agarose
beads (Santa Cruz Biotechnology), G sepharose and A
sepharose (GE Healthcare) as indicated and then
incubated at 4 C for 3h. If DNase1 or ethidium
bromide was used, the whole cell lysates were either
treated with 100mg/ml DNase1 (Invitrogen) for 20min
at 37 Co r5 0mg/ml ethidium bromide (Sigma) on ice for
30min. Next, the appropriate antibody was added, and
incubated at 4 C for 12h. After the addition of fresh
protein A/G plus-agarose bead, G sepharose and A
sepharose, the reaction was incubated overnight at 4 C
with rotation. The beads were washed ﬁve times in
RIPA buffer without protease inhibitors, resuspended in
SDS sample buffer and boiled for 5min. The samples were
then analyzed by western blotting using the appropriate
antibodies.
Immunostaining
To visualize g-ray- or NCS-induced foci, untreated cells or
cells treated with 100ng/ml NCS were cultured on cover-
slips coated with poly-L-lysine (Sigma). Cells were washed
twice with PBS and ﬁxed in 98% methanol for 10min,
followed by permeabilization with 0.3% Triton X-100
for 15min at room temperature. Next, the coverslips
were washed three times with PBS, followed by blocking
with 0.1% bovine serum albumin in PBS for 1h at room
temperature. The cells were double-immunostained
using primary antibodies directed against the indicated
proteins overnight at 4 C. The cells were then washed
with PBS and stained with the appropriate Alexa Fluor
488- or Alexa Fluor 594-conjugated secondary antibodies
(green and red ﬂuorescence, respectively; Molecular
Probes, Eugene, OR, USA). After washing, the coverslips
were mounted onto slides using Vectashield mounting
medium containing 4,6-diamidino-2-phenylindole (DAPI;
Vector Laboratories, Burlingame, CA, USA).
Fluorescence images were taken under a confocal micro-
scope (Zeiss LSM 510 Meta; Carl Zeiss, Jena, Germany)
and analyzed with Zeiss LSM Image Examiner software
(Carl Zeiss). For foci quantiﬁcation experiments, cells
with  10 foci were counted as MSH6 or g-H2AX
foci-positive cells and the percentage was calculated
among at least 100 cells by dividing the number of
MSH6 or g-H2AX foci-positive cells by the number of
DAPI-stained cells. The error bars represent standard
error in three independent experiments.
Cell survival assay
After treatment with NCS or IR, 5   10
2 cells were im-
mediately seeded onto a 60-mm dish in duplicate and
grown for 2–3 weeks at 37 C to allow colony formation.
Colonies were stained with 2% methylene blue in 50%
ethanol and counted. The fraction of surviving cells
was calculated as the ratio of the plating efﬁciencies of
treated cells to untreated cells. Cell survival results are
reported as the mean value±standard deviation for
three independent experiments.
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DSB repair was assayed by alkaline single-cell agarose-gel
electrophoresis as described previously. Brieﬂy, control
and MSH6-knockdown cells were treated with 100ng/ml
NCS or 5Gy of g-ray by followed by incubation in culture
medium at 37 C for the indicated times. Cells were then
harvested ( 10
5 cells per pellet), mixed with low-melting
temperature agarose, and layered onto agarose-coated
glass slides. The slides were maintained in the dark at
4 C for all of the remaining steps. Slides were submerged
in lysis solution [10mM Tris–HCl (pH 10), 2.5MNaCl,
0.1M EDTA, 1% Triton X-100, 10% dimethyl sulfoxide]
for 1h and incubated for 30min in alkaline electrophoresis
solution (300mM NaOH, 200mM EDTA at pH >13).
After electrophoresis ( 30min at 1 V/cm tank length),
air-dried and neutralized slides were stained with 30–
50ml ethidium bromide (20mg/ml). Average comet tail
moment was scored for 40–50cells/slide using a
computerized image analysis system (Komet 5.5; Andor
Technology, South Windsor, CT, USA).
Analysis of NHEJ activity
To analyze the role of MSH6 in NHEJ in vivo, we used the
pEGFP-Pem1-Ad2 system (26). The plasmid was digested
with HindIII to remove Ad2 and generate different types
of ends. Supercoiled pEGFP-Pem1 was used as a
positive control for standardization of transfection and
analysis conditions. The pCMV-dsRed-express plasmid
(Clontech) was co-transfected with either linearized
pEGFP-Pem1-Ad2 or supercoiled pEGFP-Pem1 as a
control for transfection efﬁciency. In a typical reaction,
5 10
5 cells were transfected with 0.5mg of linearized
pEGFP-Pem1-Ad2 or 0.5mg supercoiled pEGFP-Pem1,
together with 0.5mg of pDsRed2-N1 plasmid, using
Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s recommended protocol. Twenty-four hours
after transfection, green (EGFP) and red (DsRed) ﬂuor-
escence was measured by ﬂow cytometry (FACSCalibur;
BD Biosciences, San Jose, CA, USA).
Statistical analysis
Data are presented as means±SD. Statistical compari-
sons were carried out using unpaired t-tests, and values
of P<0.01 were considered to be statistically signiﬁcant.
RESULTS
Protein interaction studies of the human Ku70 with
MSH6
A yeast two-hybrid screen of a human prostate cDNA
library using full-length human Ku70 as bait was carried
out to identify potential Ku70-binding proteins. One of
the positive clones isolated from the 2 10
6 transformants
was identiﬁed as human MSH6. To further conﬁrm
MSH60s interaction with Ku70, we contransformed
Ku70 constructs with MSH6. The transformed colonies
showed the ability to grow in medium lacking adenosin,
histidine, tryptophan and leucine (-AHLT) and to turn
blue in a b-galactosidase assay, while cells contransformed
with the control vector pGBT9 vector did not do so with
a construct containing the human MSH6 cDNA
(Supplementary Figure S1).
To determine whether Ku70 interacts with MSH6 in
human cells endogenously expressing both proteins, we
utilized immunoprecipitation assays. For production
of DSBs, HeLa cells were treated with 100ng/ml of the
radiomimetic drug NCS or 5Gy of IR. The cells were then
lysed, and endogenous MSH6 was immunoprecipitated
with a MSH6-speciﬁc antibody. Immunoprecipitates
were subjected to western blotting with an anti-Ku70
antibody. Immunoprecipitation with anti-MSH6 anti-
bodies revealed that endogenous MSH6 bound Ku70
and that treatment with NCS or IR increased the
amount of MSH6 bound to Ku70 (Figure 1A). In this
reciprocal experiments, Ku70 antibody was able to
coimmunoprecipitate MSH6 (Figure 1B), suggesting that
these proteins may interact with each other directly or
indirectly in cells. As control, normal rabbit IgG did not
coimmunoprecipitate Ku70 or MSH6, indicating that the
coimmunoprecipitation of Ku70 with MSH6 was not due
to non-speciﬁc antibody binding. Because the MSH6
protein is complexed with MSH2 to form the MutSa
heterodimer (27), we tested whether Ku70 interacts with
MSH2. When proteins were immunoprecipitated with
anti-Ku70 and then probed with anti-MSH2, MSH2 was
detected (Figure 1B, second panel).
To further document, the physiological relevance of the
interaction, we investigated whether MSH6 interacts with
other components of the NHEJ system by coimmunopre-
cipitation assays. NHEJ is initiated by binding of the
Ku70/86 heterodimer to both ends of the broken DNA
molecule, and this step is essential for recruitment of
DNA-PKCS (4). The assembled DNA-PKcs then exhibits
serine-threonine protein kinase and DNA end-bridging
activities (28). Finally, the XRCC4/DNA ligase IV
complex is responsible for the ligation step (29,30).
Endogenous MSH6 and Ku86 could be coimmunopre-
cipitated by anti-MSH6 antibodies (Figure 1C, second
panel), but not by control IgGs, and this was increased
after treatment of NCS. We then tested whether MSH6
binds DNA-PKCS or XRCC4 in human cells.
Immunoprecipitation of lysates using anti-MSH6
antibodies revealed that endogenous MSH6 and DNA-
PKcs did not interact in the absence of NCS, but upon
NCS treatment the interaction was found (Figure 1C,
third panel). However, interaction between MSH6 and
XRCC4 in the presence of NCS was not detected by
coimmunoprecipitation (Figure 1C, fourth panel). Since
both MSH6 and Ku70 are chromatin-bound proteins in
cells, we considered the possibility that the interaction
between MSH6 and Ku70 was mediated by the independ-
ent binding of both protein complexes to DNA. To
exclude this possibility, we pretreated cell lysates with
DNase I, or ethidium bromide (EtBr), which is known
to disrupt protein–DNA interactions, prior to
coimmunoprecipitation. Our data showed that DNA did
not mediate MSH6-Ku70 association (Figure 1D). These
results suggested that MSH6 forms a physiological
complex with Ku heterodimer in vivo.
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Figure 1. MSH6 interacts with Ku70. (A) HeLa cells were untreated (UT) or treated with 100ng/ml NCS or 5Gy ionizing radiation (IR). Proteins
were immunoprecipitated (IP) from the lysates using an anti-MSH6 antibody 3h after treatment. Immunoprecipitates were then subjected to
western-blot analysis using antibodies speciﬁc for Ku70 or MSH6. The fourth lane contain 5% input for Ku70 and 20% input for MSH6.
Normal rabbit IgG was used for negative control immunoprecipitations. (B) HeLa cells were untreated or treated with 100ng/ml NCS for 3h.
Proteins were immunoprecipitated from the lysates using an anti-Ku70 antibody. Immunoprecipitates were then subjected to western-blot analysis
using antibodies speciﬁc for MSH6, MSH2 or Ku70. The third and fourth lane contains 5% input for Ku70 and 20% input for MSH6 and MSH2.
Normal rabbit IgG was used for negative control immunoprecipitations. (C) HeLa cells were untreated or treated with 100ng/ml NCS for 3h.
Proteins were immunoprecipitated from the lysates using an anti-MSH6 antibody. Immunoprecipitates were then subjected to western-blot analysis
using antibodies speciﬁc for Ku70, Ku86, DNA-PKCS, XRCC4 or MSH6. The third and fourth lane contains 5% input for Ku70 and 20% input for
Ku86, DNA-PKcs, XRCC4 and MSH6. Normal rabbit IgG was used for negative control immunoprecipitations. (D) HeLa cells were untreated or
treated with 100ng/ml NCS for 3h. Whole cell lysates were treated with 50mg/ml ethidium bromide (EtBr) on ice for 30min (lane 3) or 100mg/ml
Continued
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and Ku70 at different time periods after treatment with
NCS. Immunoprecipitation analysis revealed that the level
of interaction between the two proteins clearly increased
by 3h after NCS treatment and further increased by 6h
after treatment, then decreased in a time-dependent
manner (Figure 1E). These observations indicate that
Ku70 and MSH6 complex formation increases at the
early onset of DSB formation and dissociates at later
time points.
To further conﬁrm this interaction, HEK293T cells
were transiently transfected with an expression con-
struct encoding full-length Ku70 tagged with HA and
a second construct that expressed full-length MSH6.
Co-immunoprecipitation assays were then performed
using an MSH6-speciﬁc antibody for immunopre-
cipitation and an anti-HA antibody for immunoblotting.
Immunoprecipitation with the anti-MSH6 antibody
revealed that MSH6 was associated with HA-tagged,
full-length Ku70 in both control and NCS-treated cells
and that the level of binding increased after NCS treat-
ment (Figure 1F). Therefore, it is likely that MSH6 forms
a complex with Ku70. In spite of this, it remains possible
that other proteins may mediate the interaction between
MSH6 and Ku70 complex because both complexes
possess a variety of interacting partners.
MSH6 forms nuclear foci and colocalizes with c-H2AX in
response to DNA damage
After DNA damage, many DNA-damage-repair proteins
are recruited to the DNA-damage sites and form discrete
DNA-damage-induced nuclear foci. The order and timing
of these events are thought to be critical for DNA repair
(31). Thus, we were interested in whether MSH6 also
forms NCS- or IR-induced nuclear foci. In untreated
HeLa cells, anti-MSH6 antibody staining yielded diffuse
nuclear staining (Figure 2A and B). Numerous nuclear
foci were apparent in cells 1h after 100ng/ml NCS treat-
ment (Figure 2A). MSH6 foci were also evident in HeLa
cells 30min after irradiation at 5Gy (Figure 2B). MSH6
foci peak at 6 or 12h after NCS or IR treatment, respect-
ively, and then signiﬁcantly declined. We also tested
whether Ku70 could form nuclear foci after NCS treat-
ment. However, Ku70 did not form nuclear foci. Ku70
staining in NCS- or IR-treated cells was weak and
diffuse throughout the nucleus (data not shown).
g-H2AX focus formation on the DSB sites is one of the
earliest events in response to forms of DNA damage that
induce DSBs (32). Based on above observations, we
investigate the potential colocalization of MSH6 and
g-H2AX into the same nuclear foci after DNA damage.
Thus, the immunoﬂuorescent staining analysis was
conducted. As shown in Figure 2C, MSH6 in the
mock-treated cells appears to be homogenously
distributed through the nucleus and g-H2AX foci was
not found. Upon NCS or IR treatment, a clear redistribu-
tion of MSH6 and g-H2AX to form discrete nuclear foci
occurred (Figure 2C and D). Some extent of colocalization
ofthesefocioccurred.Suchlimiteddegreeofcolocalization
was probably reﬂecting the fact that both MSH6 and
g-H2AX are able to interact with several protein partners
and function in multiple biological pathways in cells. A
quantitative assessment made on MSH6 and g-H2AX
colocalization by counting all of the foci in at least 50
randomly chosen untreated and NCS- or IR-treated cells
is given in Figure 2C and D, right panel. The analysis
revealed that  50% of MSH6 foci coincided with that of
g-H2AX 3 or 6h after 100ng/ml NCS or 5Gy IR treat-
ment, respectively. These results suggest that MSH6 may
relocalize to the same DSB site as g-H2AX after DNA
damage.
MSH6 knockdown suppresses NHEJ
To investigate the biological signiﬁcance of the MSH6/
Ku70 interaction, we assessed the role of MSH6 in
NHEJ. We combined the pEGFP–Pem1–Ad2 system
and short hairpin RNA (shRNA)-mediated depletion to
analyze the effects of MSH6 knockdown on the efﬁciency
of NHEJ after formation of DSBs. The reporter cassette
for detection of NHEJ activity was previously described
(26). The principal characteristic of the plasmid (pEGFP–
Pem1–Ad2) used in this assay (Figure 3A) is the interrup-
tion of the EGFP sequence by a 2.4-kb intron derived
from the rat Pem1 gene. An exon derived from adenovirus
(Ad) was introduced into the middle of the intron, and it
was ﬂanked on both sides by HindIII restriction enzyme
recognition sequences. In undigested or partially digested
plasmids, GFP is not expressed because the Ad exon is
efﬁciently incorporated into the GFP mRNA. However,
when the plasmid is linearized by HindIII digestion, the
Ad2 exon is removed, enabling expression of EGFP upon
successful intracellular recircularization. EGFP expression
can then be easily detected and quantiﬁed by ﬂow
cytometry. Transfection with the supercoiled pEGFP–
Pem1 plasmid is used to evaluate EGFP-signal expression
without the requirement for rejoining, and the pCMV-
dsRed-express plasmid is used as a control to determine
transfection efﬁciency for this assay.
Figure 1. Continued
DNase I for 20min at 37 C (lane 4) or mock-treated (lane 2). Cell lysates were then subjected to coimmunoprecipitation assays with MSH6 antibody
and detected by anti-Ku70 or anti-MSH6. The ﬁfth lane contains 5% input for Ku70 and 20% input for MSH6. (E) HeLa cells were untreated or
treated with 100ng/ml NCS, and cells were lysed at the indicated times. Whole-cell lysates were subjected to immunoprecipitation using an
anti-MSH6 antibody, and the resulting immunoprecipitates were subjected to western-blot analysis using anti-Ku70 and anti-MSH6 antibodies.
Graphs show the quantiﬁcation of the level of Ku70. The sixth lane contains 5% input for Ku70 and 20% input for MSH6. The data were
normalized to the untreated control (as the value of 1) and are the mean±SD of three independent experiments. (F) HEK293T cells were transfected
with full-length MSH6 and HA-tagged Ku70 expression vectors. After 24h, cells were untreated or treated with 100ng/ml NCS for 3h. Proteins were
immunoprecipitated from HEK293T cell lysates using an anti-MSH6 antibody, and the resulting immunoprecipitates were subjected to western-blot
analysis using anti-HA or anti-MSH6 antibodies. Graphs show the quantiﬁcation of the level of HA-Ku70. The third and fourth lane contains 20%
input. The data were normalized to the untreated control (as the value of 1) and are the mean±SD of three independent experiments.
Nucleic Acids Research,2011, Vol.39, No. 6 21350       1         3           6         12        24 h
0
20
40
60
80
N
o
.
 
o
f
 
M
S
H
6
 
f
o
c
i
 
p
e
r
 
c
e
l
l
A NCS               0                           1             3                           6                     12                       24  h
MSH6
DAPI
IR               0                                0.5            6                             12                  24    h
MSH6
DAPI
0
20
40
60
80
100
N
o
.
 
o
f
 
M
S
H
6
 
f
o
c
i
 
p
e
r
 
c
e
l
l
0            0.5              6              12             24h
B
NCS             0                       0.5                    3 12   h
MSH6
DAPI
γ γ-H2AX
merge
0         0.5         3          12 h
0
20
40
60
80
M
S
H
6
 
c
o
l
o
c
a
l
i
z
a
t
i
o
n
 
w
i
t
h
 
γ
-
H
2
A
X
 
(
%
)
C
IR              0                     0.5                     6  12  h
MSH6
γ-H2AX
DAPI
merge
0         0.5         6          12 h
0
20
40
60
M
S
H
6
 
c
o
l
o
c
a
l
i
z
a
t
i
o
n
 
w
i
t
h
 
γ
-
H
2
A
X
 
(
%
)
D
Figure 2. MSH6 forms nuclear foci that colocalize with g-H2AX after DNA damage. (A and B) HeLa cells were untreated or treated with 100ng/ml
NCS (A) or 5Gy ionizing radiation (IR) (B). At the indicated times, cells were ﬁxed and immunostained using an anti-MSH6 antibody.
Representative cells containing foci are shown. Nuclei were stained with DAPI. The number of MSH6 foci (‘Materials and Methods’ section)
determined by confocal microscopy (N=3). (C and D) HeLa cells were untreated (UT) or treated with 100ng/ml NCS (C) or 5Gy ionizing radiation
(IR) (D) and ﬁxed for the indicated time points after NCS or IR treatment. Colocalization of endogenous MSH6 and g-H2AX was detected using
antibodies speciﬁc for MSH6 and g-H2AX. MSH6 and g-H2AX antibodies were visualized with Alexa Fluor 488- or Alexa Fluor 546-conjugated
secondary antibodies, respectively, followed by confocal microscopy. Colocalization of MSH6 (green) and Ku70 (red) in cells appears yellow in
merged images. Quantiﬁcation of the percentage of foci showing colocalization between MSH6 and g-H2AX. An average of 50 merged nuclear foci
from three independent slides was analyzed for each time point.
2136 Nucleic Acids Research, 2011,Vol.39, No. 6To determine whether MSH6 plays a role in regulation
of NHEJ activity, we ﬁrst silenced MSH6 in HeLa cells
using plasmid-mediated shRNA expression technology to
create stable MSH6 knockdown cell lines (MSH6 shRNA
#1 and MSH6 shRNA #2). Immunoblotting conﬁrmed
that expression of endogenous MSH6 was reduced by
more than 90% in both cell lines stably transfected with
the two different MSH6 shRNAs in comparison to control
shRNA-transfected cells (Figure 3B).
To evaluate the efﬁciency of NHEJ, MSH6 knockdown
cells (MSH6 shRNA #1 and MSH6 shRNA #2) were
transfected with either linearized pEGFP–Pem1–Ad2 or
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Figure 3. Effect of MSH6 on NHEJ. (A) Map of the pEGFP–Pem1–Ad2 vector. The reporter substrate consists of the GFP gene under control of
the CMV promoter. The GFP gene contains an engineered intron from the rat Pem1 gene, which is interrupted by an adenoviral exon (Ad) that is
ﬂanked by HindIII recognition sites. In this construct, the GFP gene is inactive; however, after digestion with HindIII and successful NHEJ, the
construct expresses GFP. (B) HeLa cells were transfected with control or one of two different MSH6 shRNA expression vectors (MSH6 shRNA #1
and #2) and selected with 400g/ml G418. Four weeks later, the expression level of the MSH6 protein was determined by immunoblot analysis using
an anti-MSH6 antibody. Control and MSH6-knockdown HeLa cells were transfected with supercoiled pEGF–Pem1 or HindIII-linearized pEGFP–
Pem–Ad2 together with pCMV-dsRed-express. To quantify NHEJ events, the cells were analyzed by ﬂow cytometry 24 h after transfection. DsRed
expression was used to normalize transfection efﬁciency. The ratio of GFP-positive (GFP
+) to DsRed-positive (DsRed
+) cells was used as a measure
of NHEJ. Relative levels of plasmid rejoining compared to control shRNA-transfected cells were calculated by dividing the GFP
+/DsRed
+ ratios of
the samples and plotted. Means are representative of at least three independent experiments. Error bars indicate the SD. Asterisk denotes P<0.01.
(C) DLD1 cells were transiently transfected with either the control vector (PCMV6) or an MSH6 expression vector (pCMV6–MSH6). The level of
MSH6 expression in rescued cells was analyzed by western blotting using an antibody speciﬁc for MSH6. NHEJ in control and MSH6-expressing
DLD1 cells was measured using the pEGFP–Pem–Ad2 system. Means are representative of at least three independent experiments. Error bars
indicate the S.D. Asterisk denotes P<0.01.
Nucleic Acids Research,2011, Vol.39, No. 6 2137supercoiled pEGFP–Pem1 together with pDsRed2–N1.
The cells were then incubated for 24h to allow expression
of EGFP (green) and DsRed (red), followed by ﬂow
cytometry analysis. To control for the efﬁciency of trans-
fection, the ratio of GFP
+ cells to DsRed
+ cells was used
as the normalized measure of NHEJ efﬁciency. As shown
in Figure 3B, lower panel, NHEJ activity decreased sig-
niﬁcantly in both MSH6-depleted cell lines in comparison
to control cells. In three independent experiments, the
average NHEJ efﬁciency was 66.11±4.95% in the
MSH6 shRNA #1 cells and 72.81±2.44% in the MSH6
shRNA #2 cells relative to control shRNA-transfected
cells. These results indicate that MSH6 contributes to
DSB repair through regulation of NHEJ.
MSH6 expression stimulates NHEJ
The reduced NHEJ activity present in cells depleted of
MSH6 raised the possibility that restoration of MSH6 in
MMR-deﬁcient cells may increase NHEJ activity. To
assess this possibility, we utilized the human colon
cancer cell line DLD1, which is deﬁcient for MSH6 (33).
We transiently transfected DLD1 cells with the pCMV6-
hMSH6 vector, which drives expression of full-length
MSH6, or with the control pCMV6 vector. Western-blot
analysis conﬁrmed that MSH6 was highly expressed 24h
after transfection with the pcDNA3–MSH6 plasmid
(Figure 3C, upper panel). MSH6-expressing cells were
then transfected with either linearized pEGFP–Pem1–
Ad2 or supercoiled pEGFP–Pem1 together with
pDsRed2–N1, and the numbers of red and green ﬂuores-
cent cells were quantiﬁed by FACS after 24h.
Introduction of the HindIII-linearized pEGFP–Pem1–
Ad2 plasmid into MSH6-expressing DLD1 cells revealed
an  50% increase in NHEJ activity in comparison to
control DLD1 cells (Figure 3C, lower panel). These
results indicate that MSH6 is involved in regulation of
the NHEJ pathway for repair of DSBs.
MSH6 knockdown delays DNA DSB repair
To further address whether MSH6-deﬁcient cells exhibit
defects in rejoining DNA DSBs, the formation of g-H2AX
foci was analyzed. One of the primary responses to the
formation of DSBs is phosphorylation of the histone
variant H2AX at Ser193 (32). Levels of phosphorylated
H2AX (g-H2AX) and quantitative analysis of g-H2AX
foci following IR are often used as measures of DSB
induction and the efﬁciency of DNA repair. We therefore
investigated whether MSH6 knockdown affected the
formation of g-H2AX foci by immunoﬂuorescence
microscopy after NCS (Figure 4A and B) or IR treatment
(Figures 4C). In control cells, the maximum number of
g-H2AX foci were observed  1h after treatment with
100ng/ml NCS (Figure 4B) or 5Gy IR (Figure 4C).
Longer recovery times resulted in a decline in the
number of g-H2AX foci. By 6h after NCS or IR treat-
ment, g-H2AX foci were signiﬁcantly decreased,
indicating that the NCS- or IR-induced DSBs were
almost repaired. In contrast, although the formation of
g-H2AX foci was similar in control and in MSH6-deﬁcient
cells up to 30min after NCS or IR treatment, g-H2AX
foci persisted for longer time periods in MSH6-knockdown
cells compared to control cells. MSH6-knockdown cells
contained a signiﬁcant amount of g-H2AX nuclear foci
even at 6h after NCS or IR treatment.
To conﬁrm these results, we also measured the persist-
ence of DSB in NCS- or IR-treated HeLa cells stably
transfected with MSH6 or control shRNA by single-cell
electrophoresis (the comet assay). This very sensitive
method can be used to detect low levels of DNA breaks.
NCS or IR treatment induces DSBs, visible as increased
DNA mobility or ‘comet tails’. At 30min after NCS or IR
treatment, control and MSH6-knockdown cells exhibited
comparable levels of DNA damage. However, when the
persistence of unrepaired DNA-strand breaks was
analyzed at a various times after NCS or IR treatment,
cells depleted of MSH6 exhibited signiﬁcantly lower repair
efﬁciency than control cells (Figure 5A and B). Based on
the comet tail moments, which quantify the extent of
DNA damage, we estimate that  2–2.5-fold more unre-
solved DNA damage remains in MSH6-deﬁcient cells in
comparison to control cells at 6 and 12h after NCS or IR
treatment (Figure 5A and B). These results demonstrate
that MSH6 deﬁciency retards DNA repair of
NCS-induced DNA-strand breaks.
Since radiosensitivity of cells is also affected by proteins
involved in DSB repair, we monitored the survival of cells
depleted of MSH6 after exposure to NCS or IR. The
sensitivity of the cells to NCS or IR was examined by
assaying colony formation after NCS or IR treatment.
We found that inhibition of MSH6 expression reduced
the number of colonies formed within 15 days after treat-
ment with 50 and 100ng/ml NCS (Figure 6A) or 2 and
5Gy IR (Figure 6B). Taken together, results from our
functional analyses provide clear evidence that MSH6 is
involved in the efﬁcient repair of DSBs and is required for
optimal cell survival following NCS- or IR-induced DNA
damage.
DISCUSSION
MMR removes DNA mismatches that have evaded proof-
reading during DNA replication. This versatile post-
replicative repair system efﬁciently corrects single-base
mismatches and loops of up to 16 extrahelical nucleotides
that arise during replication of repetitive DNA tracts
(21,34). Repair is initiated by binding of one of two
mismatch recognition complexes that have overlapping
speciﬁcities, ensuring efﬁcient repair of all common repli-
cation errors. The MutSa and MutSb mismatch recogni-
tion complexes are heterodimers of hMSH2/hMSH6 and
hMSH2/hMSH3, respectively. The MutSa complex binds
to and participates in the repair of single base–base
mismatches and insertion/deletion loops, whereas the
MutSb complex recognizes insertion/deletion loops
larger than the single-base mispairs (27,35). Another
heterodimeric complex made up of hMLH and hPMS2
forms a ternary complex with the MutS complexes and
promotes repair via its endonucleolytic activity, leading
to excision repair of the mismatch (36).
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Figure 4. MSH6-deﬁcient cells exhibit prolonged g-H2AX staining. (A) Control and MSH6-depleted HeLa cells were untreated (0min) or treated
with 100ng/ml NCS. Whole-cell lysates were prepared at the indicated time points, and western-blot analysis was performed using speciﬁc antibodies
directed against MSH6, MSH2, Ku70 and a-tubulin. (B and C) Control and MSH6-depleted HeLa cells were untreated or treated with 100ng/ml
NCS (B) or 5 Gy ionizing radiation (C) and were then ﬁxed at the indicated times. Cells were stained with an anti-g-H2AX antibody and the DNA
was counterstained using DAPI. The percentage of g-H2AX foci positive cells determined by confocal microcscopy (N=3). Error bars represent the
mean±SD. Asterisk denotes P<0.01.
Nucleic Acids Research,2011, Vol.39, No. 6 2139In addition to their functions in post-replicative MMR,
MMR proteins also participate in many cellular processes
through associations with DNA-damage-signaling
proteins. For example, MMR proteins, including MSH2,
MSH6 and MLH1, are components of the BRCA-
1-associated genome surveillance complex, a multi-protein
complex involved in the recognition and response to
abnormal DNA structures (37). In addition, MSH2 con-
stitutively interacts with the ATR kinase to form a signal-
ing module that regulates phosphorylation of downstream
effectors, such as Chk1 (38). MLH1 and MSH2 also act as
adaptors that link ATM and Chk2 in response to DNA
damage through associations with these proteins (39).
PMS2 collaborates with p73 to enhance cisplatin-induced
apoptosis (40). The interaction between MMR and base
excision repair pathways is critical for modulating the
DNA-damage response (41). The three MutL homologs,
MLH1, PMS2 and PMS1, have been shown to interact
with a large number of proteins involved in cell-cycle regu-
lation, signaling and apoptosis (42). Therefore, identiﬁca-
tion of MMR-binding proteins and the functional
signiﬁcance of their interactions are important for under-
standing the myriad biological functions of these proteins.
In this study, we present several independent obser-
vations that document a speciﬁc interaction between
the human MMR protein MSH6 and Ku70. First, we
used yeast two-hybrid assays to show that MSH6 inter-
acts with Ku70. Second, we found that Ku70 co-immuno-
precipitates with MSH6 from HeLa cell extracts and that
this interaction is enhanced after radiomimetic NCS or
IR exposure. Third, MSH6 forms NCS- or IR-induced
nuclear foci that colocalize with g-H2AX at the sites
of DNA breaks. Finally, we showed that the interaction
between MSH6 and Ku70 regulates NHEJ activity, which
is critical for repair of DSBs. These biochemical and mor-
phological observations, as well as our functional analyses,
provide compelling evidence for a nuclear complex
consisting of MSH6 and Ku70.
Recently, several lines of evidence suggest that MMR
plays a role in repair of DSBs (2), which can be repaired
by HR (23,43–46) or NHEJ (24,25,47). However, the
underlying mechanisms by which MMR regulates DSB
repair remain unknown. In the present study, we showed
that MSH6 is readily accumulated at the sites of DSBs,
where it colocalizes with g-H2AX after NCS or IR treat-
ment (Figure 2C and D). Co-immunoprecipitation experi-
ments also revealed that MSH6 associates with Ku70
within 3h after NCS treatment and that this interaction
returns to basal levels at 12h post-NCS treatment
(Figure 1E). In addition, endogenous MSH6 and Ku86
could be coimmunoprecipitated, and this was increased
after treatment of NCS. On the other hand, endogenous
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Figure 5. MSH6 knockdown results in decreased DSB repair. (A and B) Control and MSH6-depleted HeLa cells were untreated or treated with
100ng/ml NCS (A) or 5Gy ionizing radiation (B). At the indicated time points, cells were harvested for comet tail formation assays under alkaline
conditions. Comet images were captured using ﬂuorescence microscopy, and tail moment was analyzed in 75–80 randomly chosen comets using
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2140 Nucleic Acids Research, 2011,Vol.39, No. 6MSH6 and endogenous DNA-PKcs did not interact in the
absence of NCS, but upon NCS treatment the interaction
was found (Figure 1C, third panel). However, interaction
between MSH6 and XRCC4 in the presence of NCS was
not detected by coimmunoprecipitation (Figure 1C, fourth
panel). Together, these data suggest that MSH6 may
relocalize to the DSB site following NCS or IR treatment
and work co-orporately Ku70 and play a role in early
process of NHEJ in response to DNA damage.
Therefore, we next further explored whether MSH6 is
involved in the repair of DSBs. We utilized MSH6-
deﬁcient human HeLa cells to investigate whether
MSH6 knockdown affected DSB repair using two differ-
ent assays that measure the levels of DSBs in cells exposed
to survival curve range doses of NCS, the g-H2AX and
comet assays. An early step in the cellular response to
DSBs is phosphorylation of the histone variant H2AX
(32). Numbers of g-H2AX foci have been shown to cor-
relate with DNA damage levels measured by single-cell
electrophoresis, an established method used to determine
numbers of DSBs. Using g-H2AX foci analysis as an
approach to measure DSB repair, we compared repair in
MSH6-knockdown cells and control cells treated with the
radiomimetic drug NCS. Our results showed that MSH6-
deﬁcient HeLa cells have a signiﬁcant repair defect that
was detected both by g-H2AX foci and comet tail
analyses. The initial levels of DSBs after NCS or IR treat-
ment were similar in the two MSH6 knockdown cell lines
(MSH6 shRNA #1 and #2) and in the control cells
(control shRNA) (30min; Figure 4B and C). However,
both MSH6 knockdown cell lines exhibited signiﬁcant
levels of unrejoined DSBs at 1h after exposure to NCS.
Importantly, although control cells had almost normal
levels of g-H2AX foci 3h after NCS treatment, disappear-
ance of g-H2AX foci in MSH6-deﬁcient cells was signiﬁ-
cantly delayed. Similar results were also obtained by
control and MSH6 knockdown cells exposed to IR.
Comet assay data shown in Figure 5 also indicate that
rejoining of NCS- or IR-induced DSBs was signiﬁcantly
delayed by MSH6 knockdown, similar to g-H2AX foci
measurements. These ﬁndings support a role for MSH6
in DSB repair in human cells.
NHEJ was previously reported to be decreased in
MMR-deﬁcient colon cancer cell lines in comparison to
MMR-proﬁcient cells (47). Since inactivating mutations
frequently occur in the hRAD50 and hMRE11 genes in
MMR-deﬁcient tumors (47–49), impaired expression of
these proteins has been suggested to lead to decreased
MRE11/RAD50/NBS1 complex formation, decreased
NHEJ and increased sensitivity to IR. However, the
MMR-deﬁcient colon cancer cell line DLD1, which
contains a mutation in the MSH6 gene (33), has normal
hRAD50 and hMRE11 expression but still exhibits
decreased NHEJ activity in comparison to MSH6-
proﬁcient cells (47). As described above, we demonstrated
that MSH6 interacts with Ku70 and that HeLa cells stably
expressing MSH6 shRNAs exhibit impaired ability to
repair DSBs. Thus, it seems reasonable to expect that
MSH6 contributes directly to NHEJ activity. Using an
in vivo repair assay that makes use of plasmids linearized
with HindIII to generate non-complementary ends, we
provided direct evidence that MSH6 promotes DSB-
induced NHEJ. MSH6-deﬁcient HeLa cells were shown
to exhibit an  30% reduction in HindIII-induced NHEJ
(Figure 3B). We further conﬁrmed the effects of MSH6 on
HindIII-induced NHEJ in DLD1 cells rescued with
MSH6. We found that the overexpression of MSH6 in
DLD1 cells increases NHEJ activity (Figure 3C). In
contrast to our ﬁndings, Jacob et al. (50) reported that
the ability to perform efﬁcient end joining did not
require a functional-MMR system, as no signiﬁcant
differences were observed in the rejoining efﬁciency of
NHEJ between DLD1 and DLD1-Ch2 cells containing
chromosome 2, which includes wild-type hMSH6. The
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Nucleic Acids Research,2011, Vol.39, No. 6 2141discrepancy between our results and the ﬁndings of the
previous study could be due to differing expression
levels of MSH6 between DLD1-ch2 cells and
MSH6-overexpressing DLD1 cells or due to different
methods of in vivo rejoining. Thus, further evaluation is
needed to better characterize the changes in efﬁciency of
NHEJ in cells with different levels of MSH6 using several
different methods.
Cell lines defective for any of the DSB repair genes are
generally highly sensitive to IR and have marked
deﬁciencies in DSB repair (51). Knockout or knockdown
of Ku70 (52,53) or DNA-PKCS (54) has been shown to
result in hypersensitivity to radiation. Loss of MMR
activity generally renders cells less sensitive to cell killing
by DNA-damaging agents, reﬂecting the role(s) of the
MMR system in DNA-damage signaling used to trigger
cell-cycle arrest and apoptosis (55,56). However, our data
indicate that MSH6-knockdown cells are signiﬁcantly
more sensitive to NCS and IR than control cells
(Figure 6). A similar increased sensitivity to g-irradiation
and the DNA DSB-producing drug, bleomycin, has also
been reported for MMR-deﬁcient cell lines (47,57). In the
HeLa and DLD1 cell studies described above, cells
depleted of MSH6 exhibited impaired DSB rejoining and
NHEJ, and ectopic expression of MSH6 in deﬁcient cells
restored NHEJ activity. Hence, loss of MSH6-mediated
NHEJ activation likely permits cells with broken DNA
to enter mitosis, resulting in mitotic catastrophe.
Although this is the ﬁrst report demonstrating that
MSH6 regulates MHEJ activity, many questions remain
regarding how NHEJ is actually regulated by the MSH6.
The NHEJ process is initiated by binding the Ku70/80
heterodimer to both ends of the broken-DNA molecule.
Binding of Ku to DNA is a critical step that creates a
scaffold for the assembly of the other key enzymes neces-
sary for NHEJ (58). The X-ray crystal structure of Ku
shows that it binds to DNA via a channel generated by
heterodimer formation (59). Thus, the MSH6 could
further increase the binding afﬁnity of Ku for DNA,
modulate the amount of Ku70/80 heterodimer complexes
or facilitate the recruitment of other important NHEJ
proteins to bind the broken-DNA ends. Accordingly,
studies aimed at determining the detailed mechanisms
underlying MSH6 modulation of NHEJ efﬁciency are
currently under way.
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